Torcetrapib/atorvastatin is a new and very promising lowering cholesterol drug combination from Lipitor manufacturer, Pfizer that is aimed at reducing cholesterol in a way that is unmatched by other statin drugs to lower cholesterol. Basically, Torcetrapib works by inhibiting a molecule in the liver named CETP or cholesterol ester transfer protein. CETP is responsible for transferring and regulating cholesterol in the liver.

As promising as Torcetrapib may seem to lower cholesterol and reduce the risk of heart disease, it appears that Torcetrapib, while raising HDL, the good cleansing cholesterol, also promoted to elevated blood pressure, as seen in a 1999 experiment with this drug.

A clinical trial in which 25,000 people participate will make the final conclusion regarding the fact that Torcetrapib raises blood pressure, especially if taken in high doses, what may lead to heart disease- a significant counter effect to its ability to reduce the chance of heart attacks by lowering cholesterol.

There are intentions by Pfizer to manufacture a torcetrapib-Lipitor drug combo to lower cholesterol, but this venture is not likely to be approved by the FDA, no matter how effective it may be at reducing heart disease, as this combo contradicts the law that says that no manufacturer can combine two drugs from its own line of products, that fulfill their purpose only if combined.

Taking statin drugs or any lowering cholesterol medications, either separately or combined to raise HDL and lower overall cholesterol is only one alternative. There is of course the natural solution that is not less effective. Through dietary changes, regular exercise, supplementation and relaxation practice you can lower cholesterol naturally without raising blood pressure without any side effects.